Establishment Labs Holdings (Establishment Labs Holdings) Debt-to-Equity : 10.45 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Establishment Labs Holdings Debt-to-Equity?

Establishment Labs Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.8 Mil. Establishment Labs Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $191.5 Mil. Establishment Labs Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $18.4 Mil. Establishment Labs Holdings's debt to equity for the quarter that ended in Dec. 2023 was 10.45.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Establishment Labs Holdings's Debt-to-Equity or its related term are showing as below:

ESTA' s Debt-to-Equity Range Over the Past 10 Years
Min: -21.91 Med: 0.51 Max: 10.45
Current: 10.45

During the past 8 years, the highest Debt-to-Equity Ratio of Establishment Labs Holdings was 10.45. The lowest was -21.91. And the median was 0.51.

ESTA's Debt-to-Equity is ranked worse than
99.72% of 712 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ESTA: 10.45

Establishment Labs Holdings Debt-to-Equity Historical Data

The historical data trend for Establishment Labs Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Establishment Labs Holdings Debt-to-Equity Chart

Establishment Labs Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.22

0.70

1.07

-21.91

10.45

Establishment Labs Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															-21.91	-11.43	3.39	6.20	10.45

Competitive Comparison of Establishment Labs Holdings's Debt-to-Equity

For the Medical Devices subindustry, Establishment Labs Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Establishment Labs Holdings's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Establishment Labs Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Establishment Labs Holdings's Debt-to-Equity falls into.

Establishment Labs Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Establishment Labs Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.773	+	191.451)	/	18.395
	=	10.45

Establishment Labs Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.773	+	191.451)	/	18.395
	=	10.45

Establishment Labs Holdings (NAS:ESTA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Establishment Labs Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Establishment Labs Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Establishment Labs Holdings (Establishment Labs Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Establishment Labs Holdings Inc (NAS:ESTA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

3E0:Germany

Address

Coyol Free Zone, Building B15 and 25, Alajuela, CRI

Website

https://establishmentlabs.com

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Executives

Nicholas Sheridan Lewin	director, 10 percent owner	3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Raj Denhoy	officer: Chief Financial Officer	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Dennis E Condon	director	811 ALSTON RD, SANTA BARBARA CA 93108
Leslie Gillin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Paul D. Rodio	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Samuel Ross Mansbach	other: GC & Chief Compliance Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Jw Asset Management, Llc	10 percent owner, other: See Footnote(1)	1051 N VENETIAN DRIVE, MIAMI BEACH FL 33139
Bryan Slotkin	director	C/O MOTIVA USA,.LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Ann Custin	director	C/O MOTIVA USA, LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Edward J Schutter	director	C/O FIRST HORIZON PHARMACEUTICAL CORP, 6195 SHILOH ROAD, ALPHARETTA GA 30005
Lisa Gersh	director	C/O HASBRO, INC., 1011 NEWPORT AVENUE, PAWTUCKET RI 02861
Mezerville Roberto De	officer: Chief Technology Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Renee Gaeta	officer: Chief Financial Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958
Pratip Dastidar	officer: Head of Global Operations	150 PEABODY PLACE, MEMPHIS TN 38103
Santos Salvador Dada	officer: Chief Operating Officer	C/O MOTIVA USA LLC, 16192 COASTAL HIGHWAY, LEWES DE 19958